WHO ICTRP trial
A Phase 2 Study of the Safety and Efficacy of AF37702 Injection for the…
EUCTR2008-003459-64-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-003459-64-GB |
|---|---|
| Public title | A Phase 2 Study of the Safety and Efficacy of AF37702 Injection for the Maintenance Treatment of Anemia in Subjects with Chronic Renal Failure Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa |
| Scientific title | A Phase 2 Study of the Safety and Efficacy of AF37702 Injection for the Maintenance Treatment of Anemia in Subjects with Chronic Renal Failure Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa |
| Primary sponsor | Takeda Global Research & Development Centre (Europe) Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom;Spain;Italy |
| Conditions | Anaemia MedDRA version: 9.1 Level: LLT Classification code 10058116 Term: Nephrogenic anaemia |
| Interventions | Product Code: AF37702 Pharmaceutical Form: Solution for injection Current Sponsor code: AF37702 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10- |
| Registration date | Jul 25, 2008 |
| Target size | 100 |
| Secondary IDs | AFX01_202 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: